コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ks this ubiquitylation, thus stabilizing the E2 protein.
2 tethered to cellular chromatin by the viral E2 protein.
3 omplexes of HPV-11 DNA ori bound by purified E2 protein.
4 of the hypervariable region I within the HCV E2 protein.
5 repressed by the bovine papillomavirus (BPV) E2 protein.
6 g of Brd4 was detected in the absence of the E2 protein.
7 ain, but not the DNA binding function of the E2 protein.
8 he C-terminal domain that interacts with the E2 protein.
9 hment to mitotic chromosomes by means of the E2 protein.
10 tion, leading to targeted degradation of the E2 protein.
11 onal change that leads to degradation of the E2 protein.
12 tegy using transcriptional regulation by the E2 protein.
13 ng them to mitotic chromosomes via the viral E2 protein.
14 surrounding the phosphorylation sites of the E2 protein.
15 contacts between residues across the entire E2 protein.
16 inding site derived from studies of the BPV1 E2 protein.
17 (BPV1) E2 proteins than it is to the HPV 16 E2 protein.
18 imal DNA-binding domain (DBD) from the HPV 6 E2 protein.
19 to interferon could be mediated through the E2 protein.
20 pulsing DCs with full-length recombinant PDC-E2 protein.
21 rus that expresses the bovine papillomavirus E2 protein.
22 ression is controlled by the papilloma virus E2 protein.
23 ulates gene expression by the papillomavirus E2 protein.
24 ssette in subclones expressing the wild-type E2 protein.
25 V E2 function through phosphorylation of the E2 protein.
26 ication is TopBP1, a known interactor of the E2 protein.
27 an be boosted with a single dose of purified E2 protein.
28 , and F(442), within the same epitope of the E2 protein.
29 ed epitopes for the neutralizing MAbs on the E2 protein.
30 teracting partner of the papillomavirus (PV) E2 protein.
31 nsrepression is common to different types of E2 proteins.
32 ates with pE2, a precursor containing E3 and E2 proteins.
33 onstrating that HCV virions contain apoE and E2 proteins.
34 y be a shared property of all papillomavirus E2 proteins.
35 g affinity than those displayed by the other E2 proteins.
36 together the more divergent BPV-1 and HPV-18 E2 proteins.
37 generated with some of the same recombinant E2 proteins.
38 ift from N417 to N415 in the N417S and N417T E2 proteins.
39 bovine (BPV) and human (HPV) papillomavirus E2 proteins.
40 es consists of three steps: 1) binding of an E2 protein, 2) transfer of ubiquitin from E2 to the HECT
42 cleocapsid and the cytoplasmic domain of the E2 protein, a component of the viral E1/E2 glycoprotein
43 studies confirm that both high- and low-risk E2 proteins adapt their structures on binding to DNA, al
44 We found that although different types of E2 proteins all exhibited transactivation and repression
47 ctive program through phosphorylation of the E2 protein although this is unlikely to occur through th
52 es from its heterodimer interaction with the E2 protein and forms a target membrane-inserted E1 homot
54 from its heterodimeric interaction with the E2 protein and induces the formation of a stable E1 homo
55 les from GBV-C E2-expressing cells contained E2 protein and inhibited TCR signaling in bystander T ce
56 lls that were initially activated by the HCV-E2 protein and might explain the association between HCV
57 length human papillomavirus type 11 (HPV-11) E2 protein and showed that the resultant fusion, called
58 ase enzyme activity, E1 binding to the viral E2 protein and to cellular DNA polymerase alpha-primase
59 ly active subclones expressing the wild-type E2 protein and transcriptionally silent subclones expres
60 eplication requires activities of the E1 and E2 proteins and a DNA segment containing their binding s
61 s in S phase, increases the half-life of the E2 protein, and promotes chromatin binding from S phase
71 the cottontail rabbit papillomavirus (CRPV) E2 protein as a transcriptional regulator because of the
72 2 open reading frame encodes the full-length E2 protein as well as an alternatively spliced product c
73 (FGFR3) coimmunoprecipitated with the BPV-1 E2 protein, as did human papillomavirus 31 (HPV-31) E2,
74 nalysis indicated that the HCV Core, E1, and E2 proteins assembled to form HCV-like particles (HCV-LP
75 lomaviruses since a number of papillomavirus E2 proteins associate with mitotic chromosomes independe
77 ntly identified two antibody epitopes in the E2 protein at residues 412-426 (epitope I) and 434-446 (
82 th solutions lacking Mg(2+) is observed upon E2 protein binding to sites containing the AATT, TTAA or
83 totic cells before fixation results in alpha-E2 proteins binding to the pericentromeric region of met
84 BZLF1 protein-transactivating domain and the E2 protein-binding domain was able to reactivate lytic r
86 ast, the human papillomavirus type 8 (HPV-8) E2 protein binds as large speckles at the pericentromeri
87 We have reported that the papillomavirus E2 protein binds the nuclear factor AMF1 (also called G-
88 k and low-risk HPV types, the papillomavirus E2 protein binds to four sites within the viral long con
89 ecific stages of mitosis, the papillomavirus E2 protein binds to MKlp2, and infer that association wi
90 lomavirus human papillomavirus type 8 (HPV8) E2 protein binds to the repeated ribosomal DNA genes tha
91 parate the closely related HPV-16 and HPV-18 E2 proteins but classify together the more divergent BPV
92 e that this is the authentic target of these E2 proteins but that additional factors or a specialized
93 cassette in subclones expressing the mutant E2 protein, but only into the protein binding region.
95 tivities of the bovine papillomavirus E1 and E2 proteins by modifying their DNA binding activity.
100 In the absence of other viral proteins, an E2 protein containing alanine substitutions for phosphor
101 lt, ATP, and DTT using full-length E2 and an E2 protein containing only the carboxyl-terminal DNA bin
102 terminal residues, suggesting that the GBV-C E2 protein contains a single immunodominant antigenic si
105 aromyces cerevisiae to determine whether the E2 protein could maintain plasmids containing the yeast
110 and activation of the Rb family, and the BPV E2 protein did not directly affect the expression of cel
113 , the cancer-associated human papillomavirus E2 proteins display a unique ability to detect DNA flexi
116 domain, that the identity of the cooperating E2 protein does not influence the chain type specificity
118 e diverse regulatory functions of the HPV-11 E2 protein during mRNA transcription and viral DNA repli
120 , mapped between residues 427-446 within the E2 protein, elicits antibodies that are either neutraliz
122 d is mediated by its direct association with E2 proteins encoded by cancer-inducing high risk HPV-16
124 ctors, cofactor, RNA polymerase II, and with E2 proteins encoded by HPV-16, HPV-18, HPV-11, and bovin
125 h risk HPVs may function differentially from E2 proteins encoded by low risk HPVs and animal papillom
129 could provide a mechanism to regulate E1 and E2 protein expression and DNA replication during differe
130 or the viral early protein E2, we found that E2 protein expression did not enhance the intracellular
131 iated by Brd4 interaction with virus-encoded E2 protein, facilitates viral genome segregation during
132 ing affinities of human papillomavirus (HPV) E2 proteins for different E2 binding sites have been pro
133 esents the first expression of a type 2 BVDV E2 protein from a mammalian virus vector and raises the
134 However, when we attempted to express the E2 protein from type 2 (890 strain) BVDV in a bovine her
135 c particles presented the full-length E1 and E2 proteins from a genotype 1a virus in an appropriate c
144 In an attempt to identify antibodies to E2 proteins from divergent HCV isolates, we produced HCV
150 ocalization of 13 different animal and human E2 proteins from seven papillomavirus genera, and we sho
151 We find that when coexpressed, the E1 and E2 proteins from several papillomavirus types localize t
156 together, these data indicate that the GBV-C E2 protein has a structural motif that elicits Abs that
158 lymphoma immunoglobulin test cases bound the E2 protein in a manner identical to a bona fide human an
159 Expression of the bovine papillomavirus E2 protein in cervical carcinoma cells represses express
161 S dipeptides in the hinge region of the HPV1 E2 protein in in vitro kinase assays and that HPV1 E1^E4
162 e data suggest a significant role of the HPV E2 protein in regulating late events in the HPV life cyc
164 played by the W(437)LAGLF(442) helix of the E2 protein in the hydrophobic interaction with the D-hel
165 biological activities of the papillomavirus E2 protein in transcription, replication, and maintenanc
168 eated immunization, the response to the rPDC-E2 protein increased with a gradual reduction in autoant
170 with mapping data from other UEV and related E2 proteins indicates that although the different E2/UEV
174 ious reports that recombinant, truncated HCV E2 protein inhibits NK cell functions via crosslinking o
177 -minus E1 protein was cotransported with the E2 protein into the nucleus and supported transient vira
184 utant genomes, neither the viral DNA nor the E2 protein is detected on mitotic chromosomes, while oth
191 criptional control of papillomavirus-encoded E2 protein, it is unclear how Brd4 regulates E2 function
193 on of miR_26a markedly down-regulated cyclin E2 protein levels and significantly decreased proliferat
195 ears that the higher selectivity of the HPV6 E2 protein may arise from its limited molecular adaptabi
196 Our study suggests that the function of the E2 protein may be regulated through a direct FGFR3 targe
197 These data provide evidence that the GBV-C E2 protein may contribute to the block in CD4+ T cell ex
198 r anti-E2 antibodies, suggesting that E1 and E2 proteins mediate HCV-LPs binding and, subsequently, t
204 he cellular binding target through which the E2 protein of bovine papillomavirus type 1 links the vir
206 binant adenovirus (Ad) vector expressing the E2 protein of cottontail rabbit papillomavirus (CRPV) wa
207 identified as a novel binding partner of the E2 protein of CSFV using yeast two-hybrid screening.
208 e region between residues 427 and 446 of the E2 protein of HCV genotype 1a, and we examined their cap
210 X-ray crystal structure of epitope II on the E2 protein of hepatitis C virus, in complex with nonneut
218 n is required for loading the papillomavirus E2 protein onto mitotic chromosomes and represents a kin
219 ted in reattachment of the viral DNA and the E2 protein onto mitotic chromosomes, suggesting that E1
220 sed in cells expressing either the A4 mutant E2 proteins or wild-type E2, the E2-A4 protein was much
221 articles (1.12 to 1.18 g/cm(3)), recombinant E2 protein, or control proteins, we assessed binding to
224 it is well established that the viral E1 and E2 proteins play key roles in controlling viral transcri
228 us particles with primary patient-derived E1-E2 proteins possessed biophysical properties comparable
238 host-cell genome disrupts the HPV regulatory E2 protein, resulting in a loss of negative feedback con
239 nce of the papillomavirus genome rely on the E2 protein's ability to bind that genome specifically.
246 substrate without the addition of exogenous E2 protein, suggesting that the ubiquitylation of some p
247 n-induced bending were bound more tightly by E2 proteins, supporting the indirect readout model.
250 vine papillomavirus type 1 (BPV1), where the E2 protein tethers the viral genome to mitotic chromosom
251 rsistent papillomavirus infection, the viral E2 protein tethers the viral genome to the host cell chr
255 ionally silent subclones expressing a mutant E2 protein that binds its target DNA but is unable to ac
256 of infectious HCV, we mapped regions of the E2 protein that influence a key virus-host interaction a
261 ted that H77.39 inhibited binding of soluble E2 protein to both CD81 and SR-B1, J6.36 blocked attachm
262 aining protein 4 (Brd4) interacts with viral E2 protein to mediate papillomavirus (PV) genome mainten
264 questions, we used the bovine papillomavirus E2 protein to repress the expression of either the E6 pr
265 n of the bovine papillomavirus type 1 (BPV1) E2 protein to the catalytic domain of the FokI restricti
266 apped the major phosphorylation sites of the E2 proteins to serine residues 298 and 301 and shown tha
267 iral genome levels and, like the full-length E2 protein, to repress transcription from the viral prom
269 inal signal sequence region of cdE2 affected E2 protein transport to the plasma membrane, while nonbu
271 x and subsequent release of the unconjugated E2 protein upon ubiquitin transfer to a substrate or ubi
273 ch an initial step is the association of the E2 protein via a cytoplasmic endodomain with the preasse
274 tor serine residues, the localization of the E2 protein was altered in primary human keratinocytes; w
277 ding site for the human papillomavirus (HPV) E2 protein was determined from an unbiased set of degene
278 ion between the nucleocapsid protein and the E2 protein was explored in solution using NMR spectrosco
280 imental values obtained with three different E2 proteins, we believe this to be a general and importa
285 ssion involves the reexpression of the viral E2 protein which is usually deleted in HPV-positive canc
286 double-stranded DNA viruses that encode the E2 protein, which controls transcription, replication, a
287 motile internal puncta that colocalized with E2 protein, which may represent the transport machinery
288 omosome anchor for the bovine papillomavirus E2 protein, which tethers the viral episomes to host mit
289 1bs was flexible relative to the rest of the E2 protein, which was further confirmed by MD simulation
290 ability of E2 to interact with Brd4, but an E2 protein with a mutation that disrupted C-terminal dim
292 of fusion proteins of the hepatitis C virus E2 protein with glutathione S-transferase (GST-E2) or FL
296 Exclusion required the interaction of the E2 protein with the capsid protein, a critical step in v
297 n are important for chromosomal interaction, E2 proteins with amino acid substitutions in each conser
299 PV16 and bovine papillomavirus type 1 (BPV1) E2 proteins, with the C-terminal region of Tax1BP1 inter
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。